eSonic Medical Closes over $14 Million Series B Financing for Elastography Ultrasound System

Beijing, China-based eSonic Medical (ESI) has closed over RMB 100 million ($14 million) series B financing co-led by Beijing Pharmaceutical and Health Industry Investment Fund and E-Town Capital, to strengthen its operating capacity, build its probe factory, research and develop innovative elastography ultrasound systems, and expand into overseas markets.

ESI was founded in 2020 by Jacques Souquet, French academician and world-renowned acoustics expert, and Robin Le, an experienced ultrasound industry expert who has worked as an ultrasonographer at Fuwai Hospital, General Manager of SuperSonic Imagine China, and General Manager of Philips Ultrasound in Greater China. ESI is dedicated to researching and manufacturing the latest elastography ultrasound equipment globally, which is the third-generation technology following B-mode and color Doppler ultrasound, with three categories, portable, cart-based, and and quasi-cart-based.

ESI has launched three products and has a number of products in research and development that have applied for CE mark and FDA approval. ESI is actively expanding into overseas markets and is expected to grow many times over in the future,” said Jacques Souquet, Chairman and Chief Scientist of ESI.

en_GBEnglish (UK)